Home›Stock Screener›EP Biocomposites›Financial Statements

EP Biocomposites Complete Financial Statements

6 Years of Data
2025 - 2020

In FYNone, EP Biocomposites (EPBIO) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 8.3% and ROE of 9.1%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review EP Biocomposites P/E valuation to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.33% 2025 data
EBITDA Margin 16.67% 2025 data
Operating Margin 15.00% 2025 data
Return on Assets 5.88% 2025 data
Return on Equity 9.09% 2025 data

Balance Sheet Ratios

Current Ratio 4.67 2025 data
Equity Ratio 64.71% 2025 data
Asset Turnover 0.71 2025 data

EPBIO Revenue, Net Profit & EBITDA — Year-on-Year Growth

EPBIO YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Explore EPBIO true value to estimate fundamental worth using multiple valuation models.

Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+13.3%
Year-over-Year
Equity Growth
+10.0%
Year-over-Year

EPBIO Income Statement — Revenue, EBITDA & Net Profit

EP Biocomposites revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 8.3%. For live price, earnings ratios and company overview, see EPBIO share price.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 0 12 12 7 8 3 1
Expenses 0 10 10 6 7 3 1
EBITDA 0 2 2 1 1 1 0
Operating Profit Margin % 0.00% 15.00% 12.00% 13.00% 17.00% 16.00% 8.00%
Depreciation 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0
Profit Before Tax 0 1 2 1 1 1 0
Tax 0 0 0 0 0 0 0
Net Profit 0 1 1 1 1 0 0
Earnings Per Share (₹) 0.00 6.13 6.84 3.94 9.48 6.97 0.61

EPBIO Balance Sheet — Assets, Liabilities & Shareholders' Equity

EPBIO total assets ₹17 Cr, total equity ₹11 Cr, total liabilities ₹ Cr (2025) — ROE 9.1%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 17 15 12 9 1 1
Current Assets 14 13 9 9 1 1
Fixed Assets 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0
Investments 0 0 0 0 0 0
Other Assets 16 15 11 9 1 1
LIABILITIES
Total Liabilities
Current Liabilities 3 1 1 2 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 11 10 8 2 0 0
Share Capital 2 2 2 1 0 0
Reserves & Surplus 9 8 7 1 0 0

EPBIO Cash Flow Statement — Operating, Investing & Financing

EP Biocomposites operating cash flow ₹-1 Cr, investing ₹0 Cr, financing ₹1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -1 -1 -1 -4 0 0
Investing Activities 0 0 0 -1 0 0
Financing Activities 1 1 3 5 0 0
Net Cash Flow 0 -1 2 0 0 0